Pulished Date October, 2018
ID: 1537
Share on
Share on

North America Prostate Cancer Market By Diagnostic Techniques (Digital Rectal Exam (DRE) And Prostate Specific Antigen Test (PSA)), By Surgery (Radical Prostatectomy, Orchidectomy And Trans Urethral Resection (TUR)), By Radiation Therapy (External Beam Radiation Therapy (3D Conformal Radiation Therapy, Intensity Modulated Radiation Therapy, Stereotactic Body Radiation Therapy And Proton Beam Radiation Therapy) And Brachytherapy (Permanent Brachytherapy And Temporary Brachytherapy)), By Chemotherapy (Docetaxel, Etoposide, Vinblastine, Carboplatin And Vinorelbine), And By Region - Industry Analy

Pulished: October, 2018
ID: 1537
Pages: 145

North America Prostate Cancer Market was worth $19.57 billion in 2018 and estimated to be growing at a CAGR of 8.97%, to reach $30.06 billion by 2023. North America is the largest market for prostate cancer. This is rising as there is constant input for innovative drugs to cure the diseases.

Prostate cancer is cancer which occurs in a man’s prostate. It is one of the most widespread types of cancer in men. This type of cancer generally grows gradually and initially remains limited to the prostate gland where it may not cause severe harm. This market needs new drugs that will address the unmet needs low cost and enhanced survival time.

Market for Prostate cancer is increasing due to a rise in prostate cancer population. Prostate cancer market will also be increased by the expected approval of nine late-stage pipeline products within the forecast period. There has been much growth in the prostate cancer therapeutics market over the past decade, with a number of products targeting advanced forms of the disease and showing greatly increased efficacy over their predecessors. Side effects associated with the treatment of cancer are hindering the market growth.

The North America Prostate Cancer market is segmented on the basis of diagnostic techniques into Digital Rectal Exam (DRE) and Prostate Specific Antigen Test (PSA). Based on surgery the market is segregated into Radical Prostatectomy, Orchidectomy and Trans Urethral Resection (TUR). By radiation therapy, the market is bifurcated into External Beam Radiation Therapy and Brachytherapy. External bean radiation therapy segment is further divided among 3D Conformal Radiation Therapy, Intensity Modulated Radiation Therapy, Stereotactic Body Radiation Therapy and Proton Beam Radiation Therapy. Brachytherapy segment is sub segmented into Permanent Brachytherapy and Temporary Brachytherapy. On the basis of chemotherapy, segments are Docetaxel, Etoposide, Vinblastine, Carboplatin and Vinorelbine.

Based on geography the market is analysed under regions namely, USA and Canada. USA is leading the prostate cancer market in the world.

Major companies include Sanofi S.A, GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems, Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer, Johnson & Johnson, Abbott Laboratories, and Genentech etc. The market registered substantial growth in the recent years, due to the various strategies such as opting for agreements and collaborations, adopted by leading market players.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Diagnostic Techniques                           

                                5.1.1 Introduction           

                                5.1.2 Digital Rectal Exam (DRE)  

                                5.1.3 Prostate Specific Antigen Test (PSA)            

                                5.1.4 Y-o-Y Growth Analysis, By Product

                                5.1.5 Market Attractiveness Analysis, By Product               

                                5.1.6 Market Share Analysis, By Product                

                5.2 Surgery                        

                                5.2.1 Introduction           

                                5.2.2 Radical Prostatectomy       

                                5.2.3 Orchidectomy        

                                5.2.4 Trans Urethral Resection (TUR)      

                                5.2.5 Y-o-Y Growth Analysis, By Type      

                                5.2.6 Market Attractiveness Analysis, By Type     

                                5.2.7 Market Share Analysis, By Type      

                5.3 Radiation Therapy                   

                                5.3.1 Introduction           

                                5.3.2 External Beam Radiation Therapy  

                                                5.3.2.1 3D Conformal Radiation Therapy

                                                5.3.2.2 Intensity Modulated Radiation Therapy

                                                5.3.2.3 Stereotactic Body Radiation Therapy

                                                5.3.2.4 Proton Beam Radiation Therapy

                                5.3.3 Brachytherapy      

                                                5.3.3.1 Permanent Brachytherapy

                                                5.3.3.2 Temporary Brachytherapy

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5 Market Attractiveness Analysis, By Application        

                                5.3.6 Market Share Analysis, By Application         

                5.4 Chemotherapy                         

                                5.4.1 Introduction           

                                5.4.2 Docetaxel

                                5.4.3 Etoposide

                                5.4.4 Vinblastine             

                                5.4.5 Carboplatin             

                                5.4.6 Vinorelbine            

                                5.4.7 Y-o-Y Growth Analysis, By Disease Indications          

                                5.4.8 Market Attractiveness Analysis, By Disease Indications        

                                5.4.9 Market Share Analysis, By Disease Indications         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Diagnostic Techniques

                                                6.1.3.3 By Surgery

                                                6.1.3.4 By Radiation Therapy

                                                6.1.3.5 By Chemotherapy

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Diagnostic Techniques

                                                6.1.4.3 By Surgery

                                                6.1.4.4 By Radiation Therapy

                                                6.1.4.5 By Chemotherapy

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Diagnostic Techniques

                                                6.1.5.3 By Surgery

                                                6.1.5.4 By Radiation Therapy

                                                6.1.5.5 By Chemotherapy

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Sanofi S.A                    

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GlaxoSmithKline                      

                8.3 AstraZeneca               

                8.4 AbbVie                         

                8.5 Varian Medical Systems                        

                8.6 Elekta                           

                8.7 Theragenics               

                8.8 Pfizer                            

                8.9 Novartis                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Prostate Cancer Market By Diagnostic Techniques , From 2018-2023 ( USD Billion )
  2. North America Digital Rectal Exam (DRE) Market By Region, From 2018-2023 ( USD Billion )
  3. North America Prostate Specific Antigen Test (PSA) Market By Region, From 2018-2023 ( USD Billion )
  4. North America Prostate Cancer Market By Surgery, From 2018-2023 ( USD Billion )
  5. North America Radical Prostatectomy Market By Region, From 2018-2023 ( USD Billion )
  6. North America Orchidectomy Market By Region, From 2018-2023 ( USD Billion )
  7. North America Trans Urethral Resection (TUR) Market By Region, From 2018-2023 ( USD Billion )
  8. North America Prostate Cancer Market By Radiation Therapy , From 2018-2023 ( USD Billion )
  9. North America External Beam Radiation Therapy Market By Region, From 2018-2023 ( USD Billion )
  10. North America Brachytherapy Market By Region, From 2018-2023 ( USD Billion )
  11. North America Prostate Cancer Market By Chemotherapy , From 2018-2023 ( USD Billion )
  12. North America Docetaxel Market By Region, From 2018-2023 ( USD Billion )
  13. North America Etoposide Market By Region, From 2018-2023 ( USD Billion )
  14. North America Vinblastine Market By Region, From 2018-2023 ( USD Billion )
  15. North America Carboplatin Market By Region, From 2018-2023 ( USD Billion )
  16. North America Vinorelbine Market By Region, From 2018-2023 ( USD Billion )
  17. United States Prostate Cancer Market By Diagnostic Techniques , From 2018-2023 ( USD Billion )
  18. United States Prostate Cancer Market By Surgery, From 2018-2023 ( USD Billion )
  19. United States Prostate Cancer Market By Radiation Therapy , From 2018-2023 ( USD Billion )
  20. United States Prostate Cancer Market By Chemotherapy , From 2018-2023 ( USD Billion )
  21. Canada Prostate Cancer Market By Diagnostic Techniques , From 2018-2023 ( USD Billion )
  22. Canada Prostate Cancer Market By Surgery, From 2018-2023 ( USD Billion )
  23. Canada Prostate Cancer Market By Radiation Therapy , From 2018-2023 ( USD Billion )
  24. Canada Prostate Cancer Market By Chemotherapy , From 2018-2023 ( USD Billion )
  25. North America Prostate Cancer Market By External Beam Radiation Therapy , From 2018-2023 ( USD Billion )
  26. North America 3D Conformal Radiation Therapy Market By Region, From 2018-2023 ( USD Billion )
  27. North America Intensity Modulated Radiation Therapy Market By Region, From 2018-2023 ( USD Billion )
  28. North America Stereotactic Body Radiation Therapy Market By Region, From 2018-2023 ( USD Billion )
  29. North America Proton Beam Radiation Therapy Market By Region, From 2018-2023 ( USD Billion )
  30. United States Prostate Cancer Market By External Beam Radiation Therapy , From 2018-2023 ( USD Billion )
  31. Canada Prostate Cancer Market By External Beam Radiation Therapy , From 2018-2023 ( USD Billion )
  32. North America Prostate Cancer Market By Brachytherapy, From 2018-2023 ( USD Billion )
  33. North America Permanent Brachytherapy Market By Region, From 2018-2023 ( USD Billion )
  34. North America Temporary Brachytherapy Market By Region, From 2018-2023 ( USD Billion )
  35. United States Prostate Cancer Market By Brachytherapy, From 2018-2023 ( USD Billion )
  36. Canada Prostate Cancer Market By Brachytherapy, From 2018-2023 ( USD Billion )

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients

Research Areas